|
Press Kit |
|
Media Centre |
|
Artemisinin & Malaria Treatment fact sheet
Biography Brief s Board of Directors
Project Status updates
Downloadable articles and supplements
DEG Horizons - DEG January 2008 Life + Science - IFC 2007 Africa Journal - Acumen Fund December 2006 Recent Projects - Advanced Consulting
|
|
‘Patient’ Capital for an Africa That Can’t Wait By THOMAS L. FRIEDMAN OP-ED COLUMNIST Published: April 20, 2007 New York Times
Last week, I was touring northern Tanzania when our car passed the small town of Karatu and we suddenly came upon an open field splashed with colors so bright and varied it looked from afar as if someone had painted a 30-color rainbow on the landscape. As we got closer, I discovered that it was Karatu's huge clothing market. Merchants had laid out blankets piled with multicolored shirts, pants and dresses, much of it used clothing from Europe, and were hawking their goods.
|
|
Recent News Coverage
03.06.2008 Kenya Industrialisation minister, EPZ trip uncovers woes of investors and workers “The aim of my ministry is to steer our investors into seizing control of the value chain, right from raw material to finished products,” the minister said after touring Botanical Extracts EPZ Ltd - a firm which extracts and exports artemisinin, a malaria drug raw material. Published in Business daily Africa -the International window into East Africa Business >>Read 04.06.2008 Kenya: Growing resistance in East Africa Article Published in In-Depth: Killer Number One: The fight against malaria 18.04.2008 DEG awards credit to manufacturers of malaria drugs in Kenya Published in EPO Newsletter >>Read 2008 Issue 1 Wormword against Malaria Published in DEG Horizons Issue 1 2008 16.07.2007 Killer Number One: The fight against malaria Published in IRIN In-Depth
|
